Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2014; 4(8): 064-068


Antihyperglycaemic activity of the flavonoid-rich fraction of the extract of Tamarindus indica L. on experimentally induced hyperglycaemic wistar rats

Yerima Musa, Anuka Joseph, Salawu Oluwasukanmi, Abdu-Aguye Ibrahim, Tanko Yusuf.




Abstract

Diabetes is the most common endocrine disease and its prevalence is reaching epidemic proportion worldwide. More than 10% of the population is affected by diabetes mellitus and it is the fifth most common cause of death worldwide. Tamarindus indica is a slow growing tree that is resistant to strong winds and perennial. The stem-bark extract of the plant is used locally for the management of diabetes. The flavonoids-rich portion of the stem-bark extract of Tamarindus indica L. was investigated for its hypoglycemic action on experimentally induced hyperglycaemic Wistar rats. The oral LD50 of the extract was found to be 1,265 mg/kg. The flavonoid-rich fraction lowered the blood glucose level in the three doses used (100, 200 and 400 mg/kg) there was a significant reduction with the 400 mg/kg dose at the 8th, 16th and 24th hour and the 200 mg/kg dose at 16 and 24 hours, and the 100 mg/kg dose at 24 hours. The flavonoid-rich portion of Tamarindus indica Linn significantly lowered elevated blood glucose level in the experimental animal models.

Key words: Alloxan, fructose, Hyperglycemia, metformin, Tamarindus indica






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.